about
Effects of Brassicaceae Isothiocyanates on Prostate CancerDisseminated tumor cells and dormancy in prostate cancer metastasisMitochondria-Mediated Anticancer Effects of Non-Thermal Atmospheric Plasma.Cytotoxic and chemosensitization effects of Scutellarin from traditional Chinese herb Scutellaria altissima L. in human prostate cancer cells.Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma.Bone Microenvironment Changes in Latexin Expression Promote Chemoresistance.Suppression of prostate cancer progression by cancer cell stemness inhibitor napabucasin.Prognostic factors of first-line docetaxel treatment in castration-resistant prostate cancer: roles of neutrophil-to-lymphocyte ratio in patients from Northwestern China.Improving circulating tumor cells enumeration and characterization to predict outcome in first line chemotherapy mCRPC patients.Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts.Downregulation of miR-199a-5p promotes prostate adeno-carcinoma progression through loss of its inhibition of HIF-1α.The orally active pterocarpanquinone LQB-118 exhibits cytotoxicity in prostate cancer cell and tumor models through cellular redox stress.MiR-204 enhances mitochondrial apoptosis in doxorubicin-treated prostate cancer cells by targeting SIRT1/p53 pathway.Identification of zinc finger protein of the cerebellum 5 as a survival factor of prostate and colorectal cancer cells.MiR-1268b confers chemosensitivity in breast cancer by targeting ERBB2-mediated PI3K-AKT pathway.A Triphenylphosphonium-Functionalized Mitochondriotropic Nanocarrier for Efficient Co-Delivery of Doxorubicin and Chloroquine and Enhanced Antineoplastic Activity.Reversal of 5-fluorouracil resistance by EGCG is mediate by inactivation of TFAP2A/VEGF signaling pathway and down-regulation of MDR-1 and P-gp expression in gastric cancer.Quercetin reverses the doxorubicin resistance of prostate cancer cells by downregulating the expression of c-met.The association of HIF-1α expression with clinicopathological significance in prostate cancer: a meta-analysis
P2860
Q26749086-57B7EC58-0F7F-4DC9-B28D-36E2376528F1Q26768484-7218E5BB-53D3-426D-BB56-F8275C5AE365Q33468117-94E45F4A-4C04-4694-BD7F-B3761EDC63E8Q38664995-47A73305-3EDF-461C-A351-6A2009FFD571Q38720813-ED7DEB06-7550-4E60-B44F-B482FC3B255EQ38721352-5F9F566A-1207-4E7E-88C9-8D4428F0AE03Q38792113-91CC262B-05E4-43C9-86FD-BEEBCDCD22A7Q38978620-E74EE753-5514-4446-86F0-F2513D6ABE6DQ41550939-A31DF010-685D-46CA-862F-633CE69339B1Q41557851-0AE9498C-DA1D-4AC0-B9CA-9FCD4835786DQ45324940-A5576B86-024C-4FAC-9E15-3B46421BE538Q46268309-9343D480-E225-4DC5-852D-02C960E2035CQ47098435-14F886DB-AB27-44EB-8ABB-F6E22137461EQ47100299-08360273-9528-4B95-B30C-93F96336CF72Q47107454-1757C80E-4858-469D-BF6A-3889F7985867Q47161087-B4535755-EB10-4AED-A3AA-0C9116BD16B4Q47403641-AB75AD62-C45A-408B-B173-570373384E37Q49731583-9012BB41-D790-4CCE-AFE1-A8F79EB69D34Q57107650-6EAE1A7D-4C46-4EDC-8420-365F57ED1D9E
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Insights into Chemoresistance of Prostate Cancer
@ast
Insights into Chemoresistance of Prostate Cancer
@en
Insights into Chemoresistance of Prostate Cancer
@nl
type
label
Insights into Chemoresistance of Prostate Cancer
@ast
Insights into Chemoresistance of Prostate Cancer
@en
Insights into Chemoresistance of Prostate Cancer
@nl
prefLabel
Insights into Chemoresistance of Prostate Cancer
@ast
Insights into Chemoresistance of Prostate Cancer
@en
Insights into Chemoresistance of Prostate Cancer
@nl
P2093
P2860
P921
P3181
P356
P1476
Insights into Chemoresistance of Prostate Cancer
@en
P2093
P2860
P304
P3181
P356
10.7150/IJBS.11439
P407
P577
2015-08-01T00:00:00Z